fda glp-1 warning 2025 november warns 30 telehealth firms over illegal sales Pharmacovigilance analysis of neurological adverse

When you are on a GLP-1 medication, your appetite is significantly lower, which means you might not be eating as much fiber-rich produce as you used to

The evolving debate over GLP-1 coverage will demand ongoing analysis and adjustment, and this report aims to inform all stakeholders with a comprehensive, evidence-based perspective

Unreliable Advertising Claims On September 9, 2025, President Trump issued a memorandum calling on FDA Commissioner Makary and the U.S

PeptIQ lets you log your protocol, track subjective improvements (skin, energy, recovery), and monitor across cycles so you're not just guessing

10.1093/toxsci/kfu222 68 LoftisJ